Cited 45 times in
Ability of Nafamostat Mesilate to Prolong Filter Patency during Continuous Renal Replacement Therapy in Patients at High Risk of Bleeding: A Randomized Controlled Study
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.